PubMed · 2013

ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves neuropathic symptoms in patients with sarcoidosis

Dahan A, Dunne A, Swartjes M, et al. (2013). ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves neuropathic symptoms in patients with sarcoidosis. Mol Med.

Mol Med

Source: https://pubmed.ncbi.nlm.nih.gov/23382130/

Last reviewed July 14, 2026. By the PeptIQ team.

View original source

Peptides linked in PeptIQ Wiki

ARA-290 — community report

This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.